Form 4 for FLGT Fulgent Genetics, Inc.

Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001209191-23-013290 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-02-27	2023-02-23	FLGT	KIM PAUL	CFO, Treas	A - Grant	$0.00	+16.4K	223.2K	+8%	$0
	2023-02-27	2023-02-23	FLGT	KIM PAUL	CFO, Treas	F - Tax	$31.65	-741	236.7K	-0.3%	-$23.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-02-23	A	A	14,218	$0.00	237,403	D	—	—	(F2) Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
2	Common	Common Stock	2023-02-23	F	D	741	$31.65	236,662	D	—	—	(F3) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022.
3	Common	Common Stock	2023-02-23	A	A	2,142	$0.00	223,185	D	—	—	(F1) Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022.